TY  - GEN
AU  - Gonzalez-Perez, Maria
AU  - Montes-Casado, Maria
AU  - Conde-San Román, Patricia
AU  - Cervera Hernandez, Isabel
AU  - Baranda Prellezo, Jana
AU  - Berges-Buxeda, Marcos Joaquín
AU  - Perez-Olmeda, Mayte
AU  - Sanchez-Tarjuelo, Rodrigo
AU  - Utrero-Rico, Alberto
AU  - Lozano-Ojalvo, Daniel
AU  - Torre, Denis
AU  - Schwarz, Megan
AU  - Guccione, Ernesto
AU  - Camara, Carmen
AU  - Llópez-Carratalá, Maria del Rosario
AU  - Gonzalez-Parra, Emilio
AU  - Portoles, Pilar
AU  - Ortiz, Alberto
AU  - Portoles, Jose
AU  - Ochando, Jordi
PY  - 2022
DO  - 10.3389/fimmu.2022.845882
UR  - http://hdl.handle.net/20.500.12105/14871
AB  - Long-term hemodialysis (HD) patients are considered vulnerable and at high-risk of developing severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection due to their immunocompromised condition. Since COVID-19 associated mortality...
LA  - eng
PB  - Frontiers Media
KW  - COVID-19
KW  - SARS-CoV-2 vaccine
KW  - Cellular response
KW  - Chronic kidney disease
KW  - Hemodialysis
KW  - Humoral response
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Antibodies, Viral
KW  - BNT162 Vaccine
KW  - Humans
KW  - Immunity, Humoral
KW  - Longitudinal Studies
KW  - RNA, Messenger
KW  - Renal Dialysis
KW  - SARS-CoV-2
KW  - Vaccination
TI  - Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
TY  - research article
ER  -